| | | | |
CUSIP No. 92242Y100 | | 13D | | Page 19 of 26 Pages |
Explanatory Note
This Amendment No. 8 to Schedule 13D amends and supplements the Schedule 13D filed with the United States Securities and Exchange Commission (the “SEC”) on September 3, 2014 (as amended to date, the “Statement”), relating to the equity shares, par value Re. 1 per equity share (the “Equity Shares”) of Vedanta Limited (formerly known as Sesa Sterlite Limited), a corporation incorporated under the laws of the Republic of India (the “Issuer”). Capitalized terms used herein without definition shall have the meaning set forth in the Statement.
ITEM 2. | Identity and Background |
Item 2 of the Statement is hereby amended and supplemented as follows to add the following Reporting Persons:
Vedanta UK Investment Limited (“UK Investment”); and
Vedanta Netherland Investment BV (“Netherland”).
Netherland is a wholly owned subsidiary of UK Investment, which is a wholly owned subsidiary of VRHL. UK Investment is a company registered in the United Kingdom. Netherland is a company registered in the Netherlands.
The address of the principal business office of UK Investment is 4th Floor, 30 Berkeley Square, London W1J 6EX. The address of the principal business office of Netherland is Strawinskylaan 1143, C-11, 1077 XX Amsterdam, The Netherlands.
Information with respect to the directors and officers of UK Investment, including the name, present principal occupation or employment and citizenship of its director, is listed on the attached Annex A, which is incorporated herein by reference.
During the past five years, none of the Reporting Persons or Related Persons (i) has been convicted in any criminal proceeding (excluding traffic violations or similar misdemeanors) or (ii) was a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.
ITEM 5. | Interest in Securities of the Issuer |
Item 5 of the Statement is hereby amended and restated in its entirety by inserting the following information:
(a) – (b)
The following sets forth, as of the date of this Statement, the aggregate number and percentage of Equity Shares beneficially owned by each of the Reporting Persons, as well as the number of Equity Shares as to which each Reporting Person has the sole power to vote or to direct the vote, sole power to dispose or to direct the disposition, or shared power to dispose or to direct the disposition of as of the date hereof, based on 3,717,196,639 Equity Shares outstanding as of April 16, 2021.